Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation.

Dixon BS, VanBuren JM, Rodrigue JR, Lockridge RS, Lindsay R, Chan C, Rocco MV, Oleson JJ, Beglinger L, Duff K, Paulsen JS, Stokes JB; FHN study.

BMC Nephrol. 2016 Jan 22;17:12. doi: 10.1186/s12882-016-0223-9.

2.

Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.

Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, Greene T, Larive B, Beck GJ, Gassman J, Kliger AS, Stokes JB; FHN Trial Group.

Hemodial Int. 2015 Jul;19(3):386-401. doi: 10.1111/hdi.12255. Epub 2015 Jan 5.

3.

Adrenalectomy for adrenal-mediated hypertension: National Surgical Quality Improvement Program analysis of an institutional experience.

Shada AL, Stokes JB, Turrentine FE, Simpson VB, Padia SH, Carey RM, Hanks JB, Smith PW.

Am Surg. 2014 Nov;80(11):1152-8.

PMID:
25347508
4.

Donor risk index predicts graft failure reliably but not post-transplant infections.

Rosenberger LH, Gillen JR, Hranjec T, Stokes JB, Brayman KL, Kumer SC, Schmitt TM, Sawyer RG.

Surg Infect (Larchmt). 2014 Apr;15(2):94-8. doi: 10.1089/sur.2013.035. Epub 2013 Nov 27.

5.

Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.

Walters DM, Stokes JB, Adair SJ, Stelow EB, Borgman CA, Lowrey BT, Xin W, Blais EM, Lee JK, Papin JA, Parsons JT, Bauer TW.

PLoS One. 2013 Oct 18;8(10):e77065. doi: 10.1371/journal.pone.0077065. eCollection 2013.

6.

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial.

Chan CT, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, Pierratos A, Stokes JB; Frequent Hemodialysis Network Daily Trial Group.

Nephrol Dial Transplant. 2014 Jan;29(1):168-78. doi: 10.1093/ndt/gft212. Epub 2013 Sep 26.

7.

Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2106-16. doi: 10.2215/CJN.03280313. Epub 2013 Aug 22.

8.

Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.

Walters DM, Lindberg JM, Adair SJ, Newhook TE, Cowan CR, Stokes JB, Borgman CA, Stelow EB, Lowrey BT, Chopivsky ME, Gilmer TM, Parsons JT, Bauer TW.

Neoplasia. 2013 Feb;15(2):143-55.

9.

Minimally invasive surgery fellowship does not adversely affect general surgery resident case volume: a decade of experience.

Hallowell PT, Dahman MI, Stokes JB, LaPar DJ, Schirmer BD.

Am J Surg. 2013 Mar;205(3):307-11; discussion 311. doi: 10.1016/j.amjsurg.2013.01.005.

PMID:
23414954
10.

Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.

Ronzaud C, Loffing-Cueni D, Hausel P, Debonneville A, Malsure SR, Fowler-Jaeger N, Boase NA, Perrier R, Maillard M, Yang B, Stokes JB, Koesters R, Kumar S, Hummler E, Loffing J, Staub O.

J Clin Invest. 2013 Feb;123(2):657-65. doi: 10.1172/JCI61110. Epub 2013 Jan 25.

11.

Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.

Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, Mehta RL, Kliger AS, Stokes JB; Frequent Hemodialysis Network (FHN) Trial Group.

Am J Kidney Dis. 2013 Feb;61(2):228-37. doi: 10.1053/j.ajkd.2012.09.009. Epub 2012 Nov 11.

12.

Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.

Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):851-5. doi: 10.2215/CJN.12811211. Epub 2012 Mar 22.

13.

Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.

Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):856-60. doi: 10.2215/CJN.12821211. Epub 2012 Mar 22.

14.

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.

Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):844-50. doi: 10.2215/CJN.12791211. Epub 2012 Mar 22.

15.

Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S; Frequent Hemodialysis Network (FHN) Trial Group.

Circ Cardiovasc Imaging. 2012 Mar;5(2):251-61. doi: 10.1161/CIRCIMAGING.111.969923. Epub 2012 Feb 23.

16.

Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison.

Stokes JB.

Blood Purif. 2012;33(1-3):160-4. doi: 10.1159/000334159. Epub 2012 Jan 20.

17.

Nocturnal hemodialysis: analysis following the Frequent Hemodialysis Network trial.

Stokes JB.

Semin Dial. 2011 Nov-Dec;24(6):614-20. doi: 10.1111/j.1525-139X.2011.01001.x. Epub 2011 Nov 29.

PMID:
22122449
18.

Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.

Stokes JB, Adair SJ, Slack-Davis JK, Walters DM, Tilghman RW, Hershey ED, Lowrey B, Thomas KS, Bouton AH, Hwang RF, Stelow EB, Parsons JT, Bauer TW.

Mol Cancer Ther. 2011 Nov;10(11):2135-45. doi: 10.1158/1535-7163.MCT-11-0261. Epub 2011 Sep 8.

19.

Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway.

Arroyo JP, Lagnaz D, Ronzaud C, Vázquez N, Ko BS, Moddes L, Ruffieux-Daidié D, Hausel P, Koesters R, Yang B, Stokes JB, Hoover RS, Gamba G, Staub O.

J Am Soc Nephrol. 2011 Sep;22(9):1707-19. doi: 10.1681/ASN.2011020132. Epub 2011 Aug 18.

20.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

21.

Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.

Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM.

Ann Surg Oncol. 2011 Dec;18(13):3657-65. doi: 10.1245/s10434-011-1832-y. Epub 2011 Jun 17.

PMID:
21681380
22.

Use of a falciform ligament pedicle flap to decrease pancreatic fistula after distal pancreatectomy.

Walters DM, Stokes JB, Adams RB, Bauer TW.

Pancreas. 2011 May;40(4):595-9. doi: 10.1097/MPA.0b013e3182153a4e.

PMID:
21499214
23.

Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.

Walters DM, Lapar DJ, de Lange EE, Sarti M, Stokes JB, Adams RB, Bauer TW.

Ann Surg Oncol. 2011 Oct;18(10):2764-71. doi: 10.1245/s10434-011-1693-4. Epub 2011 Apr 12.

24.

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, de Lange EE, Rich TA, Adams RB, Bauer TW.

Ann Surg Oncol. 2011 Mar;18(3):619-27. doi: 10.1245/s10434-010-1456-7. Epub 2011 Jan 7.

PMID:
21213060
25.

Oxygen regulation of the epithelial Na channel in the collecting duct.

Husted RF, Lu H, Sigmund RD, Stokes JB.

Am J Physiol Renal Physiol. 2011 Feb;300(2):F412-24. doi: 10.1152/ajprenal.00245.2010. Epub 2010 Dec 1.

26.

Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.

Suneja M, Murry DJ, Stokes JB, Lim VS.

Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E55-64. doi: 10.1152/ajpendo.00438.2010. Epub 2010 Oct 19.

27.

The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods.

Go AS, Parikh CR, Ikizler TA, Coca S, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Zappitelli M, Liu KD, Reeves WB, Ghahramani N, Devarajan P, Faulkner GB, Tan TC, Kimmel PL, Eggers P, Stokes JB; Assessment Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury Study Investigators.

BMC Nephrol. 2010 Aug 27;11:22. doi: 10.1186/1471-2369-11-22.

28.

Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.

Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM.

Ann Surg Oncol. 2010 Dec;17(12):3129-36. doi: 10.1245/s10434-010-1154-5. Epub 2010 Jun 29.

PMID:
20585879
29.

Recruitment and training for home hemodialysis: experience and lessons from the Nocturnal Dialysis Trial.

Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS Jr; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1614-20. doi: 10.2215/CJN.02440310. Epub 2010 Jun 24.

30.

Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials.

Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, Chertow GM; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1429-38. doi: 10.2215/CJN.01090210. Epub 2010 Jun 24.

31.

Effects of reduced intradialytic urea generation rate and residual renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal dialysis.

Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV, Stokes JB; Frequent Hemodialysis Network (FHN) Trial Group.

Semin Dial. 2010 Jan-Feb;23(1):19-24. doi: 10.1111/j.1525-139X.2009.00688.x.

PMID:
20331814
32.

Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Stein CS, Yancey PH, Martins I, Sigmund RD, Stokes JB, Davidson BL.

Am J Physiol Cell Physiol. 2010 Jun;298(6):C1388-400. doi: 10.1152/ajpcell.00272.2009. Epub 2010 Mar 10.

33.
34.

Metabolism of haem in Caco-2 cells.

Uc A, McDonagh AF, Stokes JB.

Exp Physiol. 2010 Feb;95(2):296-303. doi: 10.1113/expphysiol.2009.050203. Epub 2009 Oct 30.

35.

ASN policy on managing conflicts of interest.

Stokes JB, Haupt A, Molitoris BA, Kokemueller P, Ibrahim T; ASN Committee on Corporate Relations; ASN Council.

J Am Soc Nephrol. 2009 Sep;20(9):1853-9. doi: 10.1681/ASN.2009060676. No abstract available.

36.

Managing conflicts of interest: the road ahead.

Stokes JB, Berns AS, Henrich WL, McKinney TD, Molitoris BA, Palmer BF; ASN Committtee on Corporate Relations.

J Am Soc Nephrol. 2009 Sep;20(9):1860-2. doi: 10.1681/ASN.2009060677. Epub 2009 Aug 27. No abstract available.

37.

Mice defective in Trpm6 show embryonic mortality and neural tube defects.

Walder RY, Yang B, Stokes JB, Kirby PA, Cao X, Shi P, Searby CC, Husted RF, Sheffield VC.

Hum Mol Genet. 2009 Nov 15;18(22):4367-75. doi: 10.1093/hmg/ddp392. Epub 2009 Aug 18.

38.

Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis.

Stokes JB, Graw KS, Dengel LT, Swenson BR, Bauer TW, Slingluff CL Jr, Ledesma EJ.

J Clin Oncol. 2009 Aug 10;27(23):3772-7. doi: 10.1200/JCO.2008.20.8272. Epub 2009 Jul 6.

39.

Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia.

Holstein SA, Stokes JB, Hohl RJ.

Leuk Res. 2009 Feb;33(2):344-7. doi: 10.1016/j.leukres.2008.07.029. Epub 2008 Oct 2.

PMID:
18835038
40.

Salt-sensitive hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2.

Shi PP, Cao XR, Sweezer EM, Kinney TS, Williams NR, Husted RF, Nair R, Weiss RM, Williamson RA, Sigmund CD, Snyder PM, Staub O, Stokes JB, Yang B.

Am J Physiol Renal Physiol. 2008 Aug;295(2):F462-70. doi: 10.1152/ajprenal.90300.2008. Epub 2008 Jun 4.

41.

Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.

Lee CJ, Scheiman J, Anderson MA, Hines OJ, Reber HA, Farrell J, Kochman ML, Foley PJ, Drebin J, Oh YS, Ginsberg G, Ahmad N, Merchant NB, Isbell J, Parikh AA, Stokes JB, Bauer T, Adams RB, Simeone DM.

J Gastrointest Surg. 2008 Feb;12(2):234-42. Epub 2007 Nov 27.

PMID:
18040749
42.

Discordant effects of corticosteroids and expression of subunits on ENaC activity.

Husted RF, Volk KA, Sigmund RD, Stokes JB.

Am J Physiol Renal Physiol. 2007 Sep;293(3):F813-20. Epub 2007 Jul 3.

43.

Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.

Shi PP, Cao XR, Qu J, Volk KA, Kirby P, Williamson RA, Stokes JB, Yang B.

Am J Physiol Renal Physiol. 2007 May;292(5):F1334-44. Epub 2007 Jan 16.

44.

Tin protoporphyrin induces intestinal chloride secretion by inducing light oxidation processes.

Uc A, Reszka KJ, Buettner GR, Stokes JB.

Am J Physiol Cell Physiol. 2007 May;292(5):C1906-14. Epub 2007 Jan 10.

45.

Proactive versus reactive: the effect of experience on performance in a critical care simulator.

Young JS, Stokes JB, Denlinger CE, Dubose JE.

Am J Surg. 2007 Jan;193(1):100-4.

PMID:
17188098
46.

Mice heterozygous for beta-ENaC deletion have defective potassium excretion.

Cao XR, Shi PP, Sigmund RD, Husted RF, Sigmund CD, Williamson RA, Stokes JB, Yang B.

Am J Physiol Renal Physiol. 2006 Jul;291(1):F107-15. Epub 2006 Mar 28.

47.

Gallium-inducible transferrin-independent iron acquisition is a property of many cell types: possible role of alterations in the plasma membrane.

Olakanmi O, Stokes JB, Britigan BE.

J Investig Med. 2005 Apr;53(3):143-53. doi: 10.2310/6650.2005.00310.

PMID:
15921034
48.

Nedd4-2 isoforms differentially associate with ENaC and regulate its activity.

Itani OA, Stokes JB, Thomas CP.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F334-46. Epub 2005 Apr 5.

49.

Hemin induces active chloride secretion in Caco-2 cells.

Uc A, Husted RF, Giriyappa RL, Britigan BE, Stokes JB.

Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G202-8. Epub 2005 Mar 31.

50.

Supplemental Content

Loading ...
Support Center